Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. results from a prospective study

Marco Enea, Calogero Camma', Giuseppe Cabibbo, Livia Maccio, Rosina Critelli, Aimilia Karampatou, Elena Turola, Erica Villa, Fabiola Milosa, Paola Todesca, Cristian Caporali, Guido Marzocchi, Mariagrazia Dal Buono, Teresa Pollicino, Stefano Ballestri, Elena Bertolini, Filippo Schepis, Maria Luz Martinez-Chantar, Teresa Pollicino, Elena BertoliniGiorgio Enrico Gerunda, Nicola De Maria, Umberto Cillo, Gianluigi Giannelli, Patrizia Pontisso, Paola Loria, Barbara Lei, Luisa Losi, Stefano Colopi

Risultato della ricerca: Articlepeer review

155 Citazioni (Scopus)


Objective The biological heterogeneity of hepatocellular carcinoma (HCC) makes prognosis difficult. We translate the results of a genome-wide high-throughput analysis into a tool that accurately predicts at presentation tumour growth and survival of patients with HCC.Design Ultrasound surveillance identified HCC in 78 (training set) and 54 (validation set) consecutive patients with cirrhosis. Patients underwent two CT scans 6 weeks apart (no treatment in-between) to determine tumour volumes (V-0 and V-1) and calculate HCC doubling time. Baseline-paired HCC and surrounding tissue biopsies for microarray study (Agilent Whole Human Genome Oligo Microarrays) were also obtained. Predictors of survival were assessed by multivariate Cox model.Results Calculated tumour doubling times ranged from 30 to 621 days (mean, 107 +/- 91 days; median, 83 days) and were divided into quartiles: <= 53 days (n= 19), 54-82 days (n= 20), 83-110 days (n= 20) and >= 111 days (n= 19). Median survival according to doubling time was significantly lower for the first quartile versus the others (11 vs 41 months, 42, and 47 months, respectively) (p< 0.0001). A five-gene transcriptomic hepatic signature including angiopoietin-2 (ANGPT2), delta-like ligand 4 (DLL4), neuropilin (NRP)/tolloid (TLL)-like 2 (NETO2), endothelial cell-specific molecule-1 (ESM1), and nuclear receptor subfamily 4, group A, member 1 (NR4A1) was found to accurately identify rapidly growing HCCs of the first quartile (ROC AUC: 0.961; 95% CI 0.919 to 1.000; p< 0.0001) and to be an independent factor for mortality (HR: 3.987; 95% CI 1.941 to 8.193, p< 0.0001).Conclusions The hepatic five-gene signature was able to predict HCC growth in individual patient and the consequent risk of death. This implies a role of this molecular tool in the future therapeutic management of patients with HCC.
Lingua originaleEnglish
pagine (da-a)861-869
Numero di pagine9
Stato di pubblicazionePublished - 2016

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2715???


Entra nei temi di ricerca di 'Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. results from a prospective study'. Insieme formano una fingerprint unica.

Cita questo